Mile High Gummy Company
Premier Gummy Manufacturer
GLP-1 Support Gummy Formulation
GLP-1 support is one of the fastest-growing categories in the supplement industry — and one that almost no gummy contract manufacturer has built dedicated formulation expertise around.
Mile High Gummy Company is developing custom gummy formats for brands building products in this space, from appetite-support blends to nutrient formulations designed to complement GLP-1 medication regimens.
Why GLP-1 Support Is a Different Formulation Problem
Brands entering the GLP-1 support category are typically working with ingredient combinations that carry their own formulation challenges — and a gummy format adds constraints that a capsule or powder doesn't have to solve for:
-
Dosing precision matters more, not less. Consumers using GLP-1 support products are often managing appetite changes, nutrient gaps, or side-effect mitigation alongside a medication regimen. A gummy format needs consistent, verifiable dosing across every piece — not an average.
-
Nutrient density without palatability tradeoffs. Many GLP-1 support formulations lean on ingredients like B-vitamins, electrolytes, protein-adjacent compounds, or fiber — several of which carry the same bitterness and mouthfeel challenges we solve for across our broader flavor masking work.
-
Stability under real-world conditions. As with any active-ingredient gummy, a formula that holds up in a lab test isn't automatically one that holds up in a bottle sitting in a bathroom cabinet or a shipped package in July.
This is where general-purpose gummy manufacturers without dedicated formulation R&D tend to struggle — and where a category this new rewards a manufacturer willing to actually invest in the formulation science rather than repurpose an existing template.
How We Approach GLP-1 Support Formulation
Our process for GLP-1 support gummies follows the same rigorous path as any high-stakes active ingredient project:
-
Feasibility review of your target actives, dosing goals, and label claims
-
Bench formulation addressing taste, texture, and active compatibility with your specific ingredient set
-
Stability testing, including accelerated and real-time protocols, to confirm potency holds through full shelf life
-
Pilot batch validation before any commercial-scale commitment
If your formula includes actives with known heat or moisture sensitivity, we'll flag that during feasibility review — before you've invested in a full development cycle around an approach that won't hold up at scale.
A Category Still Being Defined — And Worth Claiming Early
Most gummy manufacturers haven't published anything on GLP-1 support formulation, largely because the category itself is still new enough that dedicated processes haven't been built out industry-wide.
That's an opportunity for brands moving into this space now: working with a formulation partner willing to build the R&D rigor around a new category, rather than trying to force it into an existing generic gummy template.
Frequently Asked Questions
Do you have experience formulating GLP-1 support products specifically?
GLP-1 support is an emerging category we're actively building dedicated formulation protocols around, applying the same active-ingredient stability, dosing precision, and taste-masking expertise we use across high-active-load and hard-to-mask formulations.
What kinds of ingredients are typically used in GLP-1 support gummies?
This varies by brand and product goal — common categories include B-vitamins, electrolytes, fiber, and other nutrient-support ingredients, each with different formulation considerations for taste and stability in a gummy matrix.
Can GLP-1 support actives be combined with other ingredients in one gummy?
Often, yes, though it depends on the specific actives, their compatibility, and your target dose per piece. This is exactly what feasibility review is designed to assess before bench development begins.
Is a gummy format appropriate for every GLP-1 support ingredient?
Not always. Some actives are better suited to other delivery formats due to heat sensitivity, dosing volume, or stability constraints — we'll tell you honestly during feasibility review if that's the case for your formulation.
